Melitracen hydrochloride

Melitracen hydrochloride用途

Melitracen hydrochloride 是一种具有口服活性的双相抗抑郁药和抗焦虑药。Melitracen hydrochloride 可以通过突触前膜抑制 Norepinephrine 和 5-HT (5-羟色胺) 的吸收,从而诱导突触空间中单胺递质的增加。

点击显示

Melitracen hydrochloride名称

[ CAS 号 ]:
10563-70-9

[ 中文名 ]:
盐酸美利蒽

[ 英文名 ]:
Melitracen hydrochloride

[中文别名 ]:

盐酸美利曲辛

[英文别名 ]:

U 24973A
EINECS 234-150-5
Thymeol hydrochloride
Dixeran
Melitracene hydrochloride
U-24,973A
MELITRACEN HYDROCHLORIDE
Melitracen HCl
N 7001
Trausabun

Melitracen hydrochloride生物活性

[ 描述 ]:

[ 相关类别 ]:

研究领域 >> 神经疾病

信号通路 >> G 蛋白偶联受体/G 蛋白 >> 5-HT受体

信号通路 >> 神经信号通路 >> 5-HT受体

[ 靶点 ]

5-HT receptor[1]

[体内研究]

单次口服丙咪嗪或美利曲嗪可使小鼠出现明显且持久的瞳孔扩大。美利曲辛的散瞳作用更显著,持续时间更长。美利他嗪对行为兴奋更有效。单次口服美利曲辛可降低脑干、大脑皮层、脾脏和肾上腺中的儿茶酚胺水平[2]。每日给药13周和15周后,大鼠脑干、大脑皮层和脾脏儿茶酚胺水平均未见明显变化。然而,肾上腺中的肾上腺素水平略有下降[2]。

[参考文献]

[1]. Xiaoqian Zhou , et al. The Efficacy of Flupentixol-Melitracen in the Adjuvant Therapy of Ulcerative Colitis in the Chinese Population: A Meta-Analysis. Gastroenterol Res Pract. 2019 Feb 28;2019:3480732.

[2]. K Shimamoto, et al. Myriatic Effect of 9-(gamma-dimethylamino-propylidene)-10, 10-diemthyl-9, 10-dihydroanthracene Hydrochloride (Melitracen) in Mice and Rats. Acta Sch Med Univ Kioto. 1967 Jul;40(1):38-47.

Melitracen hydrochloride物理化学性质

[ 密度 ]:
1.046 g/cm3

[ 沸点 ]:
399.1ºC at 760 mmHg

[ 熔点 ]:
245-248ºC

[ 分子式 ]:
C₂₁H₂₆ClN

[ 分子量 ]:
327.891

[ 闪点 ]:
174.4ºC

[ 精确质量 ]:
327.175385

[ PSA ]:
3.24000

[ LogP ]:
5.51130

[ 外观性状 ]:
结晶固体

[ 蒸汽压 ]:
1.4E-06mmHg at 25°C

[ 折射率 ]:
1.607

[ 储存条件 ]:
Refrigerator

Melitracen hydrochloride毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :: CB0875000

CHEMICAL NAME :: delta(sup 9(10H)),gamma-Anthracenepropylamine, N,N,10,10-tetramethyl-, hydrochloride

CAS REGISTRY NUMBER :: 10563-70-9

LAST UPDATED :: 199604

DATA ITEMS CITED :: 7

MOLECULAR FORMULA :: C21-H25-N.Cl-H

MOLECULAR WEIGHT :: 327.93

WISWESSER LINE NOTATION :: L C666 BY IHJ BU3N1&1 I1 I1 &GH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 170 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: 27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,80,1972

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 96 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: 27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,80,1972

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 760 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,390,1969

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 315 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: 27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,80,1972

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 131 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: 27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,80,1972

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 275 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,390,1969

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 52 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: APTOA6 Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH Volume(issue)/page/year: 24,121,1966